Although several study groups have reported the poor prognostic role of D-557/8 or deletion in c-KIT exon 11 on recurrence free survival in resected GIST patients, the impact of mutational type of c-KIT exon 11 on survival of advanced GIST patients needs more data for further confirmation [32–34]. This evidence concerns the gene KIT and gastrointestinal stromal tumor.